BNY Mellon U.S. Equity Income Fund USD C AccRegistrati per vedere i rating |
Storico dei rendimenti | 31/03/2024 |
Crescita di 1000 (EUR) | Grafico Interattivo |
Sintesi | ||
NAV 22/04/2024 | USD 1,208 | |
Var.Ultima Quotazione | 1,07% | |
Categoria Morningstar™ | Azionari USA – Reddito | |
Categoria Assogestioni | Azionari America | |
Isin | IE00BD5M6T26 | |
Fund Size (Mil) 28/03/2024 | USD 527,57 | |
Share Class Size (Mil) 19/04/2024 | USD 0,01 | |
Entrata (max) | 5,00% | |
Spese correnti 01/03/2024 | 1,13% |
Obiettivo d'Investimento Dichiarato: BNY Mellon U.S. Equity Income Fund USD C Acc |
The Sub-Fund aims to maximise total returns from income and capital growth. The Sub-Fund invests primarily (meaning at least two-thirds of the Sub-Fund's Net Asset Value) in equity and equity-related securities (common and preferred stock, American depositary receipts and global depository receipts (collectively “Depositary Receipts”), listed real estate investment trusts (“REITs”) and master limited partnerships (“MLPs”)), issued by “large-capitalisation companies” located in the U.S. The term “large-capitalisation companies” shall be taken to include securities of companies which, at the time of purchase, have a market capitalisation of US$2 billion or above. |
Rendimenti % (EUR) | |||||||||||||
|
Gestione | ||
Nome del Gestore Inizio Gestione | ||
John Bailer 17/01/2017 | ||
Brian Ferguson 17/01/2017 | ||
Click here to see others | ||
Data di Partenza 29/10/2021 |
Pubblicità |
Indice | |
Benchmark Dichiarato | Indice di Categoria Morningstar |
S&P 500 NR USD | Morningstar US High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Composizione del Fondo BNY Mellon U.S. Equity Income Fund USD C Acc | 29/02/2024 |
|
|
Primi 5 Titoli | Settore | % |
JPMorgan Chase & Co | Finanza | 4,66 |
Medtronic PLC | Salute | 4,11 |
AT&T Inc | Servizi alla comunicazione | 3,63 |
AbbVie Inc | Salute | 3,42 |
CRH PLC | Materie prime | 3,35 |
Incremento Decremento Nuova Posizione | ||
BNY Mellon U.S. Equity Income Fund USD C Acc |